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Environmental Stndardsfor Ionizing
Radiation: Theoretical Basis for
Dose-Response Curves
by Arthur C. Upton*
The types of injury attributable to ionizing radiation are subdivided, for purposes of
risk assessment and radiological protection, into two broad categories: stochastic effects
and nonstochastic effects. Stochastic effects are viewed as probablistic phenomena,
varying in frequency but not severity as a function of the dose, without any threshold;
nonstochastic effects are viewed as deterministic phenomena, varying in both frequency
and severity as afunction ofthe dose, withclinicalthresholds. Included among stochastic
effects are heritable effects (mutations and chromosome aberrations) and carcinogenic
effects. Both types of effects are envisioned as unicellular phenomena which can result
from nonlethal injury ofindividual cells, without the necessity ofdamage to other cells.
For the induction of mutations and chromosome aberrations in the low-to-intermediate
dose range, the dose-response curve with high-linear energy transfer (LET) radiation
generally conforms to a linear nonthreshold relationship and varies relatively little with
the dose rate. In contrast, the curve with low-LET radiation generally conforms to a
linear-quadratic relationship, rising less steeply than the curve with high-LET radiation
and increasing in slope with increasing dose and dose rate. The dose-response curve for
carcinogenic effects varies widely from one type ofneoplasm to another in the intermedi-
ate-to-high dose range, in part because ofdifferences in the way large doses ofradiation
canaffectthe promotion andprogressionofdifferentneoplasms. Information aboutdose-
response relations forlow-level irradiationisfragmentary butconsistent, ingeneral, with
thehypothesis thattheneoplastic transformation mayresultfrommutation, chromosome
aberration or genetic recombination in a single susceptible cell.
Introduction
The relationship between the dose of an envi-
ronmental agent and the biological response it
may elicit can vary, depending on the response,
the conditions ofexposure and variables affecting
susceptibility (1-5). The last include the effective-
ness of repair processes and other systems capa-
ble of modifying the response. In the case of
chemicals, including radionuclides, such varia-
bles include factors influencing theuptake, distri-
bution, concentration, and metabolic fate of the
substances in question (1,2, 4). With some chemi-
cals, moreover, as opposed to radionuclides or
ionizing radiation, toxicity also depends on the
balance between enzymatic activation and inacti-
vation (1-3, 6).
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Consideration of dose-response relationships
must take into account each ofthe above sources
of variation, which involves many uncertainties
in our present state of knowledge (1-7). Hence,
efforts to define the mathematical relationship
between dose and effect under conditions of low-
level exposure in human populations must be
based on assumptions and extrapolations of un-
proven validity. The scientific basis on which
dose-effect relationships of ionizing radiation
have been analyzed, for purposes of radiological
protection, are surveyed briefly in this report.
Diversity of Effects
To Be Considered
To assess the health impact ofa given effect of
ionizing radiation, or another environmental
agent, the following questions must be addressed:(1) Is the effect reversible or irreversible? (2) Is it
stationary orprogressive? (3) What isthe relation
between its frequency (and severity) and the
dose-is there a threshold? (4) How are its fre-
quency and severity influenced by the distribu-
tion of the dose in space and time? (5) How is
susceptibility to the effect influenced by age at
exposure, sex, genetic constitution, and other
physiological factors? (6) How is the frequency or
severity ofthe effect influenced by other environ-
mental agents-are synergistic interactions with
other agents known or suspected to occur? Com-
plete answers tothese questions are seldompossi-
ble in our present state of knowledge. Neverthe-
less, for purposes of radiological protection,
radiation effects are generally divided into sto-
chastic effects and nonstochastic effects (8).
Stochastic effects are viewed as probablistic in
nature, varying in frequency, but not severity, as
a function of the dose, without any threshold.
Nonstochastic effects, in contrast, are viewed as
deterministic phenomena, varying in both fre-
quency and severity as a function of the dose.
Stochastic effects include genetic (heritable) and
carcinogenic effects, both ofwhich are envisioned
to result from nonlethal damage to individual
cells. Nonstochastic effects, onthe otherhand, are
envisionedto reflecttissue damageresulting from
the collective injury orkilling ofmany cells inthe
affected organs. Familiar examples include cata-
ract of the lens, impairment of fertility, atrophy
of blood-forming organs and nephrosclerosis.
Teratogenic effects on the developing embryo are
viewed largely as nonstochastic in nature, al-
though the possibility that some such effects are
stochastic cannot be excluded (4, 5, 8).
Studies ofthe mechanisms ofthe various radia-
tion effects in experimental animals, analyzed in
the light ofrelevant epidemiological observations
in human populations, provide a scientific basis
for assessing dose-response relationships for pur-
poses of radiological protection, as discussed be-
low.
Stochastic Effects
Genetic Effects
Genetic or heritable effects include point muta-
tions and changes in chromosome number and
structure. Each of these types of effects results
from physicochemical changes caused by the pas-
sage ofone or more ionizing particles through, or
close to, the affected gene or chromosome (5, 9-
11).
Damage to DNA
The changes in genes and chromosomes are
associated with lesions in DNA which include
single-strand and double-strand breaks,
crosslinks, and various alterations in sugar and
base moieties (5, 10). The majority ofsuch lesions
in DNA appear to repairable through the action
of enzyme systems normally present in diploid
mammalian cells (11, 12). Hence, the biological
significance ofagivenlesion maydepend as much
ontheway inwhich itisrepaired, ormisrepaired,
as on the nature of the initial lesion itself. Al-
though chromosome aberrations are generally as-
sumed to result from double-strand breaks in
DNA (5, 13), the molecular basis for a given
heritable effect of radiation cannot yet be speci-
fied in detail.
Mutations
From a wealth of experimental studies, the
frequency ofmutations is inferredto increase as a
linear, nonthreshold function ofthe dose ofradia-
tion, implying that mutation can result from tra-
versal ofthe genetic material by a single ionizing
particle. In mouse spermatogonia and oocytes,
however, the mutation frequency varies with the
dose rate of low linear energy transfer (LET)
radiation (Figs. 1 and 2) (14), indicating that the
probability ofmutational damage resulting from
traversal by a single low-LET radiation track is
disproportionally smaller than that resulting
from traversal bytwo ormore such tracks in swift
succession. This relationship, and the steeper
dose-effect curve characteristic ofhigh-LET radi-
ation, imply that the damage resulting from tra-
versal by a single low-LET radiation track, as
opposed to a high-LET radiation track, is usually
repairable (4, 5).
Another noteworthy feature ofthe curves is the
enhanced yield of mutations per unit dose that
may result from appropriately fractionated expo-
suresto low-LET radiation (Fig. 1) (14). Although
this enhancement remains to be explained con-
clusively, it indicates that susceptibility to ge-
netic damage may, under certain conditions, be
increased by a previous exposure, possibly
through effects on cell population kinetics and/or
repair processes.
Also noteworthy is the tendency for the muta-
tion frequency to pass through a maximum at
intermediate-to-high doses and to decline with
further increase inthe dose, when the radiation is
accumutlated at high dose rates (Figs. 1 and 2)
(14). The saturation of the curves at high dose
rates is attributed to interference with expression
of the induced mutations because of excessive
cellular damage (5).
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An additional feature to be noted is the reduced
yield of mutations in offspring conceived by fe-
males more than 7 weeks after irradiation (Fig. 2)
(14). This reduction denotes marked differences in
susceptibility among various oocyte maturation
stages, presumably because of variations in re-
pair capability, yet to be defined. Such differences
seriously complicate extrapolation to other ani-
mals, includinghumans, in view ofknown species
differences in the kinetics of oocyte maturation
(5).
Chromosome Aberrations
As with the dose-response curve for mutations,
the dose-response curve for chromosome aberra-
tions conforms to a linear nonthreshold function
with high-LET radiation, and to a linear-qua-
dratic function with low-LET radiation (Fig. 3)
(15). These relationships can be represented by
the expression:
Y= C x aD x bD2 (1)
where Y is the frequency ofaberrations after dose
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FIGURE 1. Frequency of specific-locus mutations in mouse
spermatogonia as a function of the dose and dose rate of
irradiation: (0, A) data for neutrons; (0, El, A) data for X-
rays and y-rays; (0) data for acute exposures; (0L) data for
fractionated exposures; (A, A) data for chronic, daily expo-
sures (14).
D, C is the frequency in nonirradiated cells, and a
and b are coefficients oflinear and quadratic dose
terms, respectively. With high-LET radiation, the
ratioalb is suchthatthe linearterm (aD) predom-
inates at all doses. With low-LET radiation, the
ratio of alb for mammalian cells is generally of
the order of100-150-namely, 10-4/10-6-sothat
the linear term (aD) predominates at doses below
100-150 rads and the quadratic term (bD2) at
higher doses (9, 15).
From these relationships it can be inferred that
the probability of producing two chromosome
breaks close enough together in space and time to
give rise to an interchange aberration is dispro-
portionally smaller for traversal by a single low-
LET radiation track than for two such traversals
in swift succession, and that a single low-LET
radiation traversal characteristically deposits
enough localized energy for such an effect only at
the ends ofits delta tracks.
Carcinogenic Effects
In experimental animals exposed at intermedi-
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FIGURE 2. Frequency of specific-locus mutations in mouse
oocytes as a function of the dose and dose rate of irradia-
tion. Symbols are the same as in Figure 1; (K) data for
matings more than 7 weeks after irradiation (14).
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FIGURE 3. Frequency ofdicentric chromosome aberrations in
human lymphocytes irradiated in vitro, as afunction ofthe
dose and dose rate ofneutrons, X-rays, and y-rays (15).
ate to high doses, the dose-response relation for
carcinogenesis varies, depending on the type of
neoplasm, the conditions of irradiation, and the
susceptibility ofthe exposed population (4, 5). To
some extent, the variations may be attributed to
the diversity ofeffects through which large doses
of radiation can conceivably promote tumor for-
mation. These include changes in cell population
kinetics, disturbances in endocrine balance, de-
pression of immunity, and other alterations af-
fecting tissue homeostasis (5, 16). In view of the
multistage nature of carcinogenesis and the
manyfactors thatcan influence theprogression of
the cancer process, one would not expect the yield
ofneoplasms per unit dose to be the same for all
tissues, organs, individuals, doses, and conditions
ofirradiation (5, 16-18).
In the low-dose region, the carcinogenic action
ofradiation is attributable to a narrower range of
effects, since injury offar fewer cells can be pre-
sumed to be involved. In fact, if the neoplasm
induced by a small dose ofradiation is assumedto
be monoclonal in origin and to arise from the
neoplastic transformation ofa single cell by dam-
age to its genes or chromosomes, then the dose-
response relationships for such oncogenic effects
should in principle be consistent with those char-
acteristic for the induction ofmutations and chro-
mosome aberrations described above.
The dose-incidence curves for most radiation-
induced neoplasms in experimental animals are,
in fact, consistent with the dose-response curves
for induction ofmutations and chromosome aber-
rations, in that: (1) the curves with high-LET
radiation are steeper, more nearly linear, and less
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FIGURE 4. Rate ofhamster embryo cell transformation invi-
tro in relation to dose of argon ions, neutrons, or X-rays
(23).
dependent on the dose rate than are the curves
with low-LET radiation; (2) the curves with low-
LET radiation tend to increase in slope with in-
creasing dose and dose rate; and (3) the curves
with both types ofradiation tend to pass through
a maximum at intermediate to high doses and to
decrease with further increase in the dose (5, 16).
These relationships can be represented by the
expression:
y = (c + aD + bD2)e - (pD + qD2) (2)
wherey is the cumulative incidence ofneoplasms,
D s the dose, C is the spontaneous incidence, a
and b are coefficients oflinear and quadratic dose
terms for cancer induction, andp and q are coeffi-
cients of linear and quadratic dose terms for cell
killing (16-19).
Interpretation of the similarities between the
dose-response relationships for induction of neo-
plasms and those for induction ofmutations and
chromosome aberrations is complicated by the
fact that the data derived from experimental ani-
mals have been obtained largely at intermediate
to high doses, where the promoting effects ofcell
killing or other forms of injury may contribute
significantly to carcinogenesis. In view of the
multistage nature of the cancer process and our
uncertainty as to the mechanism(s) ofcarcinogen-
esis at low doses, the actual shape(s) ofthe dose-
response curve(s) for low-level radiation carcino-
genesis remain(s) to be defined.
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FIGURE 5. Frequency of transformation in Ce 1oT1/2
mouse embryo fibroblasts irradiated in vitro, in relation to
dose ofX-rays and conditions ofirradiation (26).
Also complicating extrapolation into the low
dose domain is evidence, for certain types ofneo-
plasms, that the incidence per unit dose ofhigh-
LET radiation may increase with decreasing dose
and dose rate, giving a dose-effect curve that is
convex upward (20-22). While such a "suprali-
near" dose-response relationship might be attrib-
utable to heterogeneity in susceptibility among
individuals in the population at risk, such an
explanation remains speculative at present.
Efforts to analyze the dose-response relation by
investigating the kinetics ofneoplastic transfor-
mation of cells in vitro, uncomplicated by tissue
variables, have revealed curves that tend to have
some features in common with those obtained in
vivo; namely, (1) the yield of transformants per
unit dose is higher with high-LET radiation than
with low-LET radiation; (2) the yield oftransfor-
mants per unit dose oflow-LET radiation gener-
ally increases with increasing dose and dose rate;
and (3) theyield oftransformants withbothtypes
ofradiation passes through a maximum at inter-
mediate to high doses and decreases with further
increase in the dose (Fig. 4) (23). While it is
tempting to relate these resemblances between
transformation in vitro andcarcinogenesis in vivo
to a common underlying mechanism, such as the
induction of mutations or chromosomal aberra-
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FIGURE 6. Dose-response curves for skin reactions in the
mouse foot for single doses and for 10 daily fractions. For
single doses, the mean skin reaction was obtained by
averaging the daily skin reaction scores for days 8 to 29
post irradiation. For the fractionated treatment, the scores
were averaged over a period of13 to 34 days from the start
of treatment. Scores are as follows: 0.5, no definite effect;
1.0, slight reddening; 1.5, small areas ofskin breakdown,
with scaling, crusting, puffiness, and/or severe redness;
2.0, moderate areas ofskin breakdown, with small areas of
moist exudate; 2.5, large areas of skin breakdown, with
considerable moist exudate; 3.0, most of skin affected by
breakdown and moist exudate; 3.5, complete necrosis of
limb (30, 31).
tions, this interpretation is complicated by evi-
dence that the frequency of transformation in
vitro can be affected by cell plating density, time
between irradiation and subcultivation, concen-
tration ofserum inthe culturemedium, andother
variables, the effects of which remain to be ex-
plained (24, 25). It is noteworthy, for example,
that the frequency oftransformants per unit dose
may be higher in embryo fibroblasts exposed in
vitro to 0.5-1.5 Gy when the dose is delivered in
two equal fractions separated by a 5-hr interval
or is protracted over a 6-hr period, than when the
dose is delivered in a single briefexposure (Fig. 5)
(26), for reasons yet to be determined. Analysis of
the kinetics ofthe production and repair ofinjury
leading to transformation in vitro, as compared
with the induction ofmutations, chromosome ab-
errations and cell killing, may help to elucidate
the relationships among these effects in the not-
too-distant future (27).
Another difficulty complicating characteriza-
tion of the dose-response relationship is uncer-
tainty about the distribution ofradiation-induced
neoplasms as a function of the dose of radiation
and the time after exposure. When a dose is
received in a singlebriefexposure, thetime elaps-
ing until the appearance of the induced neo-
plasms varies, depending on the type ofneoplasm
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(4, 5). When a dose is accumulated over a pro-
longed period, displacement in the temporal dis-
tribution of neoplasms may reflect the influence
ofthese and other variables, the iteracting effects
ofwhich are notyetwell known (17, 18,28). Thus,
the duration of the "latent period" preceding the
appearance of radiation-induced neoplasms, the
duration of the "plateau period" when such neo-
plasms can be expected to appear in an exposed
population, and the magnitude ofthe increase in
incidence at various times during the "plateau
period" cannot be confidently predicted in any
given situation from the limited information now
available. Heuristic models have involved vari-
ous simplifying assumptions about the duration
of the "latent" and "plateau" periods. One such
model-the so-called "relative risk" model-as-
sumes thatthe carcinogenic effects ofa given dose
are expressed during the "plateau" period as a
constant increase in the relative risk ofcancer in
those ofdiffering ages, oras a constant multiple of
the spontaneous age-specific incidence (4). An-
other model-the so-called "absolute risk"
model-assumes, on the contrary, that the num-
ber of radiation-induced neoplasms is the same
for a given dose, irrespective of age-related
changes in the natural incidence withinthe popu-
lation at risk (4). Each model fits the data for
certain types of neoplasms better than the other
model, but both models are little more than over-
simplifications at best.
Nonstochastic Effects
In contrast to stochastic effects, nonstochastic
effects are expected to remain subclinical except
at doses above presumed thresholds. Since, how-
ever, the production of nonstochastic effects in-
volves various stochastic effects, including the
killing of cells (29), the dose-response relation-
ship for any given nonstochastic effect will de-
pend on the stage at which it is scored. The
relation between the severity of acute skin dam-
TIME
- RADIATION INJURY, RECOVERY AND PROGRESSIVE FIBROATROPNY IN SEQUENCE
NON-RADIATION INJURY (ACING.PATHOLO6Y) LEADING TO FISROATROPHY
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FIGURE 7. Diagrammatic representation ofthe course of two possible skin reactions after relatively heavy irradiation, viewed in
relation to time and the natural aging process. The upper line illustrates the development ofclinical complications, the middle
line illustrates a reaction that does not reach the clinically defined threshold. Trauma or infection may unmask latent injury,
however, since irradiated tissue may have reduced healing ability (32).
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Table 1. Estimated doses required to cause various types oftissue damage within five years after irradiation.a
Fraction of
1-5% 25-50% organ
Organ Injury at 5 years TD5/5 TD50/5 irradiated
Skin Ulcer, severe fibrosis 5,500 7,500 100 cm3
Oral mucosa Ulcer, severe fibrosis 6,000 7,500 50cm3
Esophagus Ulcer, stricture 6,000 7,500 75 cm3
Stomach Ulcer, perforation 4,500 5,000 100 cm3
Intestine Ulcer, stricture 4,500 6,500 100 cm3
Colon Ulcer, stricture 4,500 6,500 100 cm3
Rectum Ulcer, stricture 5,500 8,000 100 cm3
Salivary glands Xerostomia 5,000 7,000 50 cm3
Liver Liver failure, ascites 3,500 4,500 Whole
Kidney Nephrosclerosis 2,300 2,800 Whole
Bladder Ulcer, contracture 6,000 8,000 Whole
Ureters Stricture, obstruction 7,500 10,000 5-10 cm
Testes Permanent sterilization 200-600 2,000 Whole
Ovary Permanent sterilization 200-300 625-1,200 Whole
Uterus Necrosis, perforation <10,000 <20,000 Whole
Vagina Ulcer, fistula 9,000 <10,000 5 cm
Breast
Child No development 1,000 1,500 5 cm3
Adult Atrophy + necrosis <5,000 <10,000 Whole lobe
Lung Pneumonitis, fibrosis 4,000 6,000
Capillaries Telangiectasia, sclerosis 5,000-6,000 7,000-10,000
Heart Pericarditis, pancarditis 4,000 <10,000 Whole
Bone
Child Arrested growth 2,000 3,000 10 cm3
Adult Necrosis, fracture 6,000 15,000 10 cm3
Cartilage
Child Arrested growth 1,000 3,000 Whole
Adult Necrosis 6,000 10,000 Whole
CNS (brain) Necrosis 5,000 <6,000 Whole
Spinal cord Necrosis, transection 5,000 <6,000 5cm3
Eye Panophthalmitis, hemorrage 5,500 10,000 Whole
Cornea (L.B.) Keratis 5,000 <6,000 Whole
Lens Cataract 500 1,200 Whole
Ear (inner) Deafness <6,000 Whole
Vestibular Meniere's 6,000 10,000 Whole
Thyroid Hypothyroidism 4,500 15,000 Whole
Adrenal Hypoadrenalism <6,000 Whole
Pituitary Hypopituitarism 4,500 20,000-30,000 Whole
Muscle
Child No development 2,000-3,000 4,000-5,000 Whole
Adult Atrophy <10,000 Whole
Bone marrow Hypoplastic 200 550 Whole
2,000 4,000-5,000 Localized
Lymph nodes Atrophy 3,500-4,500 <7,000 Localized
Lymphatics Sclerosis 5,000 <8,000 Localized
aModified from Rubin and Casarett (33). Tabulated levels are estimates ofdose required to cause an incidence of5% (TD5/5) or
50% (TD50/5), respectively, ofeffects, with the following radiation conditions: super-voltage therapy (1-6 MeV); 1000 rad/week in
five daily fractions with a 2-day rest; and treatment completed in 2-8 weeks, depending on the total dose.
age, the radiation dose, and the duration of expo-
sure is shown schematically in Figure 6 (30, 31).
In contrast to stochastic effects, nonstochastic
effects are expected to remain subclinical except
at doses above presumed thresholds. Since, how-
ever, the production of nonstochastic effects in-
volves various stochastic effects, including the
killing of cells (29), the dose-response relation-
ship for any given nonstochastic effect will de-
pend on the stage at which it is scored. The
relation between the severity of acute skin dam-
age, the radiation dose, and the duration ofexpo-
sure is shown schematically in Figure 6 (30, 31).
In general, except forteratogenic effects, the dose-
response relation for nonstochastic effects ofclini-
cal severity is highly sigmoid, with thresholds in
the range of 1-20 Gy. For teratogenic effects on
the developing embryo, effects well below 1 Gy
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have been observed, with evidence for a high
relative biological effectiveness ofhigh-LET radi-
ations (5).
In considering dose-response relationships for
nonstochastic effects, it must be remembered that
some such effects develop slowly (Fig. 7) (32), with
the result that assessment oftheir dose-response
relationships must take into account the long
time required for their evolution.
In general, the doses required to cause nonsto-
chastic effects are large enough (Table 1) (33) so
that it is feasible to prevent their occurrence in
radiation workers by limiting the cumulative oc-
cupational lifetime exposure to subthreshold lev-
els (8).
Teratogenic effects on the developing embryo
are generally attributed to the depletion of pro-
genitor cells in embryonic anlage at critical
stages inorganogenesis. To the extent that killing
of appreciable numbers of cells in such anlage is
required to induce malformation, and that the
stages ofmaximum susceptibility to cell depletion
are sharply delimited in time, thresholds for most
such effects are presumed to exist (4, 5).
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